{"pageContent": "Background: Patient-reported outcome measures (PROMs) have become widely adopted in the care of patients with prostate cancer, but there is no validated crosswalk between two commonly used instruments, the Expanded Prostate Cancer Index Composite Short Form (EPIC-26) and the Memorial Sloan Kettering (MSK) instrument, which consists of the International Index of Erectile Function-6 (IIEF-6) questionnaire and the MSK radical prostatectomy urinary outcome scale.", "metaData": {"source": "Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles\nhttps://pubmed.ncbi.nlm.nih.gov/2016818/"}}